Looking for that something different to give for Christmas? 🎁
Well here it is!!! Make a donation to Rachael’s Ribbons of Hope to support pediatric brain tumor research and get a shirt...what a deal!!
Order yours today!!!
Here is an article we wanted to share:
The Children's Research Institute
Program for Cell Enhancement and Technologies for Immunotherapy
The Program for Cell Enhancement and Technologies for Immunotherapy (CETI), led by Catherine Bollard, M.D., is a multidisciplinary, cross-platform, translational center within the Children’s Research Institute of Children’s National Health System and the George Washington University School of Medicine & Health Sciences. It is comprised of faculty members with complementary research interests in immunology, cancer biology, clinical oncology, nanotechnology, genetic engineering, and molecular and cellular biology. By bringing together basic scientists and clinicians with expertise in cancer, transplant, infectious disease, allergy and immunology and autoimmune/inflammatory diseases, we can develop new therapies for patients that can improve outcomes for these disorders. In line with fulfilling our mission and vision, collective efforts of our team include:
- Development of new cell therapeutic products and protocols for the treatment and prevention of malignant and non-malignant diseases
- Ongoing direct translation from the bench to the bedside
- Conduct of phase I and II clinical trials to evaluate the safety and efficacy of these cellular therapies
- Immune reconstitution analysis of patients with immune-related disorders – particularly participants of our clinical trials – in order to determine avenues for improvement of current therapies
- Training of the next generation of scientists from both the medical and scientific fields on the science of cell-based therapies
- Advocacy and consulting for the responsible use of cell-based therapies
LETS HELP ALL CHILDREN LIVE BETTER AND CURE PEDIATRIC BRAIN TUMORS
Did you know?
Every Donation to pediatric brain tumor research gets us one step closer to a cure